Home
Departments
Research
Office of Commercialization and Industry Collaboration
Available Technologies
Toggle navigation
Menu
Home
Office of Commercialization and Industry Collaboration
Available Technologies
Categories
Office of Commercialization and Industry Collaboration
University of South Alabama
775 University Blvd. N.
Bldg. II, Ste. 150
Mobile, AL 36608-0002
Ph: (251) 460-7932
Fax: (251) 460-7955
techtransfer@southalabama.edu
Search Results - dna+repair+therapeutics
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Inhibition of Gli1 Increases Sensitivity to Cisplatin
OPPORTUNITY Platinum-based anticancer agents are among the most widely used agents in clinical oncology. Nucleotide excision repair (NER) is the pathway through which platinum–DNA damage is repaired and, ERCC1 is a useful biomarker for the NER process in human cells. Understanding the molecular and pharmacological control of NER may allow for...
Inventor(s):
Eddie Reed
,
Rajeev Samant
Category(s):
Cancer Therapeutics
,
DNA Repair Therapeutics
,
All Technologies